New research at MD Anderson Cancer Center has found that oxygen-deprived RNA molecules lead to tumor progression.
As tumors grow, they can outgrow their blood supply, leaving some areas of the tumor tissue oxygen starved, a condition known as tumor hypoxia. Conventional wisdom suggests the lack of oxygen would slow tumor growth. Surprisingly, the researchers found that cancer cells are able to adapt in order to keep growing. The...
Two leaders at MD Anderson Cancer Center have been elected to the Institute of Medicine (IOM) of the National Academies in recognition of...
Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging...
“Is it possible to make cancer history?”
That’s a question Ethiopian President Mulatu Teshome asked during a recent visit to MD Anderson.
“We believe so,” answered President Ronald DePinho, M.D., before adding, “but we’re not there yet.”
Getting there will require waging a global war against cancer, DePinho explained, with a focus not only on treatment, but also on prevention and early detection.
During an...
Improved surgical outcomes for ovarian cancer patients, expanded potential impact for new drugs and a novel family outreach program to head...
"The only drug that works is a drug that a patient can afford."
That's what Hagop Kantarjian, M.D., told "60 Minutes...
Known cancer-driving genomic aberrations in localized lung cancer appear to be so consistently present across tumors that a single biopsy...
During MD Anderson’s recent Moon Shots Program event, a new clinical trial aimed at detecting lung cancer at an earlier stage was highlighted...
Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection...
Since the 1940s, Pap tests have been successfully detecting cervical cancer in its early stages, before it has a chance to spread. When caught...
Innovative clinical trials that assign patients to treatment arms based on tumor biomarkers could lead to increased treatment options for...
Exosomes — tiny, virus-size particles released by cancer cells — can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They...